Plaintiff Northstar Neuroscience, Inc., and defendant Neuronetics, Inc., appear to have settled their trademark dispute over the mark NEUROSTAR. This is based on the Stipulation of Dismissal the parties jointly filed in the Western District today.
Northstar filed its complaint against Neuronetics on March 7, alleging trademark infringement, false designation of origin, cancellation of trademark registration, and common law infringement and unfair competition. The dispute arose out of Neuronetics’ use of the marks NEUROSTAR, NEUROSTAR TMS THERAPY, NEUROSTAR and Design, and NEUROSTAR TMS THERAPY and Design in connection with medical devices used to treat neurological and psychiatric disorders. Northstar had alleged those marks infringed Northstar’s prior rights to NORTHSTAR NEUROSCIENCE, which Northstar also uses in connection with neurostimulation therapies for people suffering from stroke and other neurological diseases and disorders.
Terms of the apparent settlement are not known — to STL, at least. The case has not yet been dismissed, but it will be as soon as Western District Judge John Coughenour signs the stipulated order.
The case cite is Northstar Neuroscience, Inc. v. Neuronetics, Inc., No. 07-0351 (W.D. Wash.).